Asthma UK announces partnership with spacer manufacturer
Medical Developments UK (MDUK) has become a silver corporate partner of Asthma UK, the UK’s leading asthma charity. As part of the agreement, MDUK will donate 25p to the charity from the sale of each of its spacers in the UK, including both the Space Chamber plus® and the Space Chamber plus Compact ®.
MDUK’s space chambers employ a number of unique features to improve the delivery of asthma and COPD medication. By spraying the medication into the chamber instead of directly into the mouth, a greater proportion of the drug is able to pass to the lungs. As a result, treatment is more efficient and effective, and less drug wastage reduces costs for the NHS. This is particularly important with steroidal medication because poor inhaler technique can result in greater risk of side-effects.
Expressing her delight with the partnership announcement, Asthma UK’s Clinical Lead Deborah Waddell said: “We know that the Space Chamber plus® is popular with patients and clinicians, so we are very pleased to welcome MDUK to our corporate partnership scheme.
“This vital funding enables us to conduct world-leading research towards a cure, and with our award-winning health information and support, to reach more of the 5.4 million people with asthma.”
Commenting on behalf of MDUK, Adrian Gee-Turner said: “We share a common goal with Asthma UK; to improve the delivery of asthma medication, so we are naturally delighted to become a partner and look forward to working closely with them.”